biotech

Europe's best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts…
Read More...

Two employees in pharmaceutical industry wearing protective gloves, mask, cap and white suit seen standing by the…
Read More...

Australia’s healthcare and biotechnology sector has matured into one of the most promising and strategically…
Read More...

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding…
Read More...

The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology…
Read More...

Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the…
Read More...

The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors…
Read More...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to…
Read More...